PeptiDream (OTCMKTS:PPTDF – Get Free Report) is expected to be releasing its resultson Wednesday, May 13th. Analysts expect PeptiDream to post earnings of ($0.0507) per share and revenue of $28.5930 million for the quarter.
PeptiDream Stock Performance
Shares of PPTDF stock opened at $7.59 on Tuesday. The company has a 50 day moving average of $8.04 and a 200-day moving average of $9.90. PeptiDream has a 12-month low of $7.23 and a 12-month high of $13.53.
About PeptiDream
PeptiDream Inc (OTCMKTS:PPTDF) is a Tokyo-based biopharmaceutical company specializing in the discovery and development of peptide-based therapeutics. Since its founding in 2006, the company has built a proprietary Peptide Discovery Platform System (PDPS) that combines encoded peptide libraries with high-throughput screening to identify new macrocyclic and constrained peptides. These compounds are designed to bind with high specificity and affinity to challenging targets, including protein–protein interactions that are often undruggable by conventional small molecules.
The company’s core business model centers on collaborating with global pharmaceutical and biotechnology partners, granting access to its PDPS for early?stage drug discovery programs.
Recommended Stories
- Five stocks we like better than PeptiDream
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
- 3 Stocks That Win If Inflation Surprises to the Downside
- MercadoLibre Boldly Invests in Growth: Discount Deepens
Receive News & Ratings for PeptiDream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PeptiDream and related companies with MarketBeat.com's FREE daily email newsletter.
